ecdysone has been researched along with Cancer of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blandino, G; Givol, D; Oren, M; Wang, Y | 1 |
| Mukhopadhyay, T; Nakamura, S; Roth, JA | 1 |
2 other study(ies) available for ecdysone and Cancer of Lung
| Article | Year |
|---|---|
Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs.
Topics: Antineoplastic Agents; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Ecdysone; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.
Topics: Acetylation; Amino Acid Sequence; Amino Acid Substitution; Carcinoma, Non-Small-Cell Lung; Cell Fractionation; Ecdysone; Fatty Acids, Unsaturated; Gene Expression Regulation; Genes, p53; Genes, Reporter; GTPase-Activating Proteins; Humans; Immunoblotting; Immunohistochemistry; Lung Neoplasms; Nuclear Proteins; Plasmids; Point Mutation; Precipitin Tests; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |